Australia · Delayed Price · Currency is AUD Aroa Biosurgery Company Description
Aroa Biosurgery Limited, a regenerative medicine company, engages in the developing, manufacturing, and distributing medical devices for wound and tissue repair using extracellular matrix (ECM) technology in the United States and internationally.
The company's products include Endoform Natural and Endoform Antimicrobia Restorative Bioscaffold for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and complex wounds; Myriad Morcells, a morcellized (powdered) format of Myriad Matrix for soft tissue repair and complex wounds; and Reinforced Bioscaffolds, a surgical product for use in ventral hernia repair and abdominal wall reconstruction.
Aroa Biosurgery Limited was incorporated in 2007 and is headquartered in Auckland, New Zealand.
| Country | Australia |
| Founded | 2007 |
| Industry | Medical Devices |
| Sector | Healthcare |
| CEO | Brian Ward |
Contact Details
Address: 64 Richard Pearse Drive Auckland New Zealand | |
| Phone | 64 9 869 3035 |
Stock Details
| Ticker Symbol | ARX |
| Exchange | Australian Securities Exchange |
| Fiscal Year | April - March |
| Reporting Currency | NZD |
| ISIN Number | NZARXE0001S1 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Brian Ward B.V.Sc, MBA(dist) | Founder, Chief Executive Officer, MD and Executive Director |
| James Agnew BCom, LLB | Chief Financial Officer and Joint Company Secretary |
| Rod Stanley M.Sc. | Chief Operating Officer |
| Yasmin Winchester B.Sc. | Chief of Technical Operations |
| Dr. Barnaby C.H. May Ph.D. | Chief Scientific Officer |
| Neetha Alex-Kumar | General Counsel |
| Frazer Murray | Director of Global Marketing and Strategy |
| Tracy Weimar BA, MBA | Joint Company Secretary |
| Adam Young Ph.D. | Vice President of Medical Affairs |